SCHEMBL22558

SCHEMBL22558

CC(C)OC(=O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL27974201 0.97
SCHEMBL11014727 0.97
SCHEMBL11041635 0.97 TSHR (0.48)
SCHEMBL7229497 0.82 TSHR (0.35)
SCHEMBL7237664 0.82 TSHR (0.35)
SCHEMBL4812651 0.80
SCHEMBL11133563 0.79 LMNA (0.42)
SCHEMBL72471 0.79 LMNA (0.62)
SCHEMBL229792 0.79 TSHR (0.50)
SCHEMBL1591285 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 389 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144726-A1 POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER L'OREAL (FR) 2026-05-28 US claimed
CN-119529249-A Method for producing polylactic acid-glycolic acid copolymer, and polylactic acid-glycolic acid copolymer produced by said method 中国石油大学(华东) 2025-02-28 CN claimed
CN-119350289-A Method for preparing high-purity 1, 4-dioxane-2-ketone at low cost 青岛科技大学 2025-01-24 CN claimed
CN-119350290-A Method for preparing 1, 4-dioxane-2-ketone from ethylene carbonate 青岛科技大学 2025-01-24 CN claimed
CN-112958030-B System and method for efficiently synthesizing glycolide 上海东庚化工技术有限公司 2024-07-23 CN claimed
CN-118324708-A Synthesis method of flumioxazin intermediate 6-amino-7-fluoro-2H-benzo [ b ] [1,4] oxazin-3 (4H) -ketone 山东滨农科技有限公司 2024-07-12 CN claimed
CN-115785404-B Preparation method of polyglycolic acid with adjustable hydrolysis rate and softening point 上海浦景化工技术股份有限公司 2024-06-14 CN claimed
WO-2024107400-A1 OPTICAL BRIGHTENER COMPOSITION AND LAUNDRY CARE COMPOSITION COMPRISING THE SAME MILLIKEN & COMPANY (US) 2024-05-23 WO claimed
US-20230416595-A1 WELLBORE CLEANING COMPOSITIONS AND METHODS OF MAKING AND USING SAME HALLIBURTON ENERGY SERVICES, INC. 2023-12-28 US claimed
US-20230149344-A1 BIOCHANIN A DERIVATIVES FOR TREATMENT OF BEST1-RELATED RETINOPATHIES UNIVERSITÄT REGENSBURG (AT) 2023-05-18 US claimed
WO-2012025557-A1 HETEROARYLPIPERIDINE AND -PIPERAZINE DERIVATIVES AS FUNGICIDES BAYER CROPSCIENCE AG (DE) 2012-03-01 WO claimed
CN-102216402-A Preparation for producing a cover layer of an electroluminescent security element for security and/or value documents BUNDESDRUCKEREI GMBH 2011-10-12 CN claimed
US-20080255159-A1 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM PHARMA KG (DE) 2008-10-16 US claimed
US-20080249089-A1 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM PHARMA KG (DE) 2008-10-09 US claimed
US-20040097510-A1 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-05-20 US claimed
US-6586152-B1 Useful as an ingredient of a resist composition used for preparation of semiconductor devices and the like, which comprises a compound shown by the following general formula useful as an ingredient of a resist composition used for WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2003-07-01 US claimed
CN-1420873-A Substituted phenyluracils BAYER AG (DE) 2003-05-28 CN claimed
EP-0573218-B1 4-Carboxyimidazoles as angiotensin II antagonists and their thrapeutic use SANKYO CO (JP) 2001-03-07 EP claimed
EP-1059563-A1 Agent for reducing substrate dependence of resist Wako Pure Chemical Industries, Ltd. (JP) 2000-12-13 EP claimed
CN-86101963-A LOCALIZED LIQUID ADDITIVE APPLICATION SYSTEM FOR CONTINOUS CYLINDRICAL PRODUCT 1986-10-08 CN claimed